Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06914713 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Jin-shui Huan-xian Formula for Retarding the Decline of Pulmonary Function in IPF

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 1, 2025 to Aug 1, 2025v3
  2. Start date: Apr 1, 2025 to Jun 1, 2025
    • Secondary endpoints: 29 to 27
    • Eligibility criteria expanded, about 1 word
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is to evaluate the clinical efficacy and safety of Jin-shui Huan-xian Formula in retarding the decline of pulmonary function in IPF, generate high - quality clinical evidence, and establish a treatment plan of Jin-shui Huan-xian Formula for retarding the decline of pulmonary function in Idiopathic Pulmonary Fibrosis（IPF）
Trial Details
NCT Number NCT06914713
Lead Sponsor Henan University of Traditional Chinese Medicine
Conditions
(from sponsor)		 Idiopathic Pulmonary Fibrosis(IPF)
Related terms Idiopathic Pulmonary Fibrosis
Enrollment 384 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov